中國卓銀(08039.HK)料呈請聆訊2020年1月15日舉行
格隆匯11月20日丨中國卓銀(08039.HK)公告,於2019年11月19日,董事會接獲莫雲峯(第一呈請人)及鄭蘭(第二呈請人)(統稱呈請人)於2019年11月18日根據第32章公司(清盤及雜項條文)條例於香港特別行政區高等法院提出對本公司進行清盤呈請。
呈請乃因本公司未能結付指稱債務(另加利息)總額526.99萬港元而提出。呈請人指稱本公司已資不抵債且無法支付判定債務,故對本公司進行清盤屬公正且公平。預計呈請聆訊將於2020年1月15日舉行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.